论文部分内容阅读
Objectives ESC/EAS Guidelines for the management of dyslipidaemias in 2011 recommended patients with documented coronary artery disease (CAD) or type 2 diabetes mellitus (DM) be risk-stratified into very high risk category and that the treatment targets for low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apo B) be <1.8 mmol/L and <0.8 g/L, respectively.